Evidence map›Paper›PMID 25332571›Full record

ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2014

Philadelphia chromosome positive pre-T cell acute lymphoblastic leukemia: a rare case report and short review.

Shailendra Prasad Verrma, Tarun Kumar Dutta, K V Vinod, Biswajit Dubashi, Kishore Kumar Ariga

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. International journal of molecular sciences · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Chronic Myeloid Leukemia: Beyond BCR-ABL1.Current hematologic malignancy reports · 2018
    Review
  7. Article
  8. The Philadelphia chromosome in leukemogenesis.Chinese journal of cancer · 2016
    Review
  9. P190Case reports in oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shailendra Prasad VerrmaDivision of Clinical Haematology, Department of Medicine, JIPMER, Pondicherry, India.
Tarun Kumar DuttaDivision of Clinical Haematology, Department of Medicine, JIPMER, Pondicherry, India.
K V VinodDepartment of Medicine, JIPMER, Pondicherry, India.
Biswajit DubashiDepartment of Medical Oncology, JIPMER, Pondicherry, India.
Kishore Kumar ArigaDepartment of Medicine, JIPMER, Pondicherry, India.
Jawaharlal Institute of Post Graduate Medical Education and Research · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pre-T cell acute lymphoblastic leukemia is a relatively rare leukemia. Twenty to 30 % of adult B cell leukemia cases are Philadelphia chromosome positive and it has a therapeutic and prognostic significance. Incidence and outcome of Ph+ T cell acute lymphoblastic leukemia (T cell ALL) is unknown. Only about 25 cases of de novo Ph+ T cell ALL and 44 cases of Ph+ T ALL in blastic phase of CML has been reported. Differentiation between Ph+ Pre-T ALL/LBL and T cell lymphoblastic crises of chronic myeloid leukemia may be difficult. We report a case of adult T cell ALL having Philadelphia chromosome as the cytogenetic abnormality. He was treated with acute lymphoblastic leukemia induction chemotherapy and Imatinib and achieved complete remission.

Indexed as

Philadelphia chromosome positive (Ph+)T cell acute lymphoblastic leukemia (T cell ALL)

Identifiers

PMID25332571
PMCPMC4192242
OpenAlexW1973963106

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.